摘要：In an environment of real world evidence, patient reported outcomes, expanding expedited and conditional review pathways for the treatment not only for cancers, but for a broad spectrum of serious and life-threatening diseases, we must care more than ever about pharmacovigilance via more regular and creative risk management plans to be sure, but also through a more diligent effort to understand just what “safety and surveillance” is about in the 21 st century. At least part of the solution lies with something called “Artificial Intelligence.”
其他摘要：In an environment of real world evidence, patient reported outcomes, expanding expedited and conditional review pathways for the treatment not only for cancers, but for a broad spectrum of serious and life-threatening diseases, we must care more than ever about pharmacovigilance via more regular and creative risk management plans to be sure, but also through a more diligent effort to understand just what “safety and surveillance” is about in the 21 st century. At least part of the solution lies with something called “Artificial Intelligence.”
关键词：Pharmacovigilance; Artificial Intelligence; Drug Safety
Loading...
